$MEDE
Medies

2022 Q3 Form 10-Q Financial Statement

#000168316822006918 Filed on October 17, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q1
Revenue $1.598K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $1.598K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.947K
YoY Change
% of Gross Profit 121.84%
Operating Expenses $7.237K
YoY Change
Operating Profit -$5.639K
YoY Change
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $48.00
YoY Change
Pretax Income -$5.591K
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.591K -$639.00
YoY Change
Net Earnings / Revenue -349.87%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 4.034M shares
Diluted Shares Outstanding 4.034M shares

Balance Sheet

Concept 2022 Q3 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $14.59K $400.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $14.59K $400.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $34.62K $38.51K
YoY Change
Goodwill
YoY Change
Intangibles $34.71K $26.66K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $69.33K $65.17K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $14.59K $400.00
Total Long-Term Assets $69.33K $65.17K
Total Assets $83.92K $65.57K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $0.00 $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $49.50K $40.31K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $38.00K $25.50K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $49.50K $40.31K
Total Long-Term Liabilities $38.00K $25.50K
Total Liabilities $87.50K $65.81K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$16.17K -$639.00
YoY Change
Common Stock $520.00 $400.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.578K -$239.00
YoY Change
Total Liabilities & Shareholders Equity $83.92K $65.57K
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q1
OPERATING ACTIVITIES
Net Income -$5.591K -$639.00
YoY Change
Depreciation, Depletion And Amortization $1.947K
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Central Index Key
EntityCentralIndexKey
0001918694
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-08-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-264308
dei Entity Registrant Name
EntityRegistrantName
Medies
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1651594
dei Entity Address Address Line1
EntityAddressAddressLine1
2100 Geng Road, Suite 210
dei Entity Address City Or Town
EntityAddressCityOrTown
Palo Alto
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94303
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
719-3983
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5195000 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14586 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
400 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
14586 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
400 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
34713 usd
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26659 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34619 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38513 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
69332 usd
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
65172 usd
CY2022Q3 us-gaap Assets
Assets
83918 usd
CY2022Q1 us-gaap Assets
Assets
65572 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
49496 usd
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
40311 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
49496 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
40311 usd
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
12500 usd
CY2022Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
0 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
25500 usd
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
25500 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
38000 usd
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
25500 usd
CY2022Q3 us-gaap Liabilities
Liabilities
87496 usd
CY2022Q1 us-gaap Liabilities
Liabilities
65811 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5195000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5195000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4000000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4000000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
520 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
400 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12071 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16169 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-639 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3578 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-239 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83918 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65572 usd
CY2022Q3 us-gaap Revenues
Revenues
1598 usd
us-gaap Revenues
Revenues
1598 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1598 usd
us-gaap Gross Profit
GrossProfit
1598 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7237 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17176 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
7237 usd
us-gaap Operating Expenses
OperatingExpenses
17176 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
48 usd
us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
48 usd
CY2022Q3 NONE Operating And Other Income Expenses
OperatingAndOtherIncomeExpenses
-7189 usd
NONE Operating And Other Income Expenses
OperatingAndOtherIncomeExpenses
-17128 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-5591 usd
us-gaap Profit Loss
ProfitLoss
-15530 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5591 usd
us-gaap Net Income Loss
NetIncomeLoss
-15530 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4034456 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4034456 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4017228 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4017228 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4000000 shares
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
400 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-639 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-239 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1195000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12191 usd
us-gaap Net Income Loss
NetIncomeLoss
-15530 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3578 usd
us-gaap Net Income Loss
NetIncomeLoss
-15530 usd
us-gaap Depreciation
Depreciation
3894 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
4446 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7190 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
12500 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12500 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12191 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
9185 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
12500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33876 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
14186 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
400 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14586 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
NONE Proceeds Of Loan From Related Party Against Acquisition Of Intangibles
ProceedsOfLoanFromRelatedPartyAgainstAcquisitionOfIntangibles
12500 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16169 usd
CY2022Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2223 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
4467 usd
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38930 usd
us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
5 years
CY2022Q3 us-gaap Depreciation
Depreciation
1947 usd
us-gaap Depreciation
Depreciation
4311 usd
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5195000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5195000 shares
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3261 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3261 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3261 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3261 usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
16169 usd

Files In Submission

Name View Source Status
0001683168-22-006918-index-headers.html Edgar Link pending
0001683168-22-006918-index.html Edgar Link pending
0001683168-22-006918.txt Edgar Link pending
0001683168-22-006918-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_014.jpg Edgar Link pending
medies_ex3101.htm Edgar Link pending
medies_ex3102.htm Edgar Link pending
medies_ex3201.htm Edgar Link pending
medies_ex3202.htm Edgar Link pending
medies_i10q-083122.htm Edgar Link pending
MetaLinks.json Edgar Link pending
none-20220831.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
none-20220831_def.xml Edgar Link unprocessable
none-20220831_lab.xml Edgar Link unprocessable
medies_i10q-083122_htm.xml Edgar Link completed
none-20220831_cal.xml Edgar Link unprocessable
none-20220831_pre.xml Edgar Link unprocessable